IP Library Granted Patent US 11,759,222
Granted Patent B2
US 11,759,222 · App. 16/928,718 · Granted Sep 19, 2023

Methods and devices to treat nasal airways

Inventors: Scott J. Wolf (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA)
Assignee: Aerin Medical Inc.
A61B17/24A61B5/01A61B17/2816A61B18/06A61B18/085A61B18/12A61B18/1206A61B18/14A61B18/1442A61B18/1445A61B18/1477A61B18/1485A61B18/16A61F5/08A61F5/56A61F7/10A61N1/403A61N5/025A61N5/0603A61N5/0625A61B17/320068A61B18/02A61B18/1815A61B18/20A61B2017/248A61B2018/00005A61B2018/0016A61B2018/0022A61B2018/00023A61B2018/0091A61B2018/00178A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00595A61B2018/00642A61B2018/00702A61B2018/00708A61B2018/00791A61B2018/00821A61B2018/00875A61B2018/00886A61B2018/00922A61B2018/00928A61B2018/00982A61B2018/00994A61B2018/0212A61B2018/0225A61B2018/0262A61B2018/044A61B2018/126A61B2018/1253A61B2018/143A61B2018/1425A61B2018/1467A61B2018/1807A61B2018/1861A61M2025/105A61N7/022F04C2270/041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,759,222
App. No.
16/928,718
Granted
Sep 19, 2023
Kind
B2
Abstract

A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.

Claims (10)

1. A method for reshaping a nasal airway in a patient, without forming an incision or leaving behind an implant, the method comprising:

advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway;

inflating the inflatable balloon with sufficient pressure to cause the inflatable balloon to press against the lateral wall to increase a nasal valve angle and thus increase a diameter of the nasal airway; and

removing the reshaping device from the nasal airway,

wherein the diameter of the nasal airway remains increased after removal of the reshaping device and healing of the nasal airway.

2. The method of claim 1 , wherein the inflatable balloon is positioned between an upper portion of the nasal septum and the lateral wall, wherein the inflatable balloon is inflated until the nasal valve angle reaches a desired size, and wherein the diameter of the nasal airway comprises a diameter at or near a nasal valve of the nasal airway.

3. The method of claim 1 , further comprising delivering energy with at least one energy delivery member coupled with the inflatable balloon to an underlying tissue beneath nasal mucosa of the nasal airway, while maintaining the balloon in an inflated configuration.

4. The method of claim 3 , wherein the at least one energy delivery member comprises at least one radiofrequency member attached to an outer surface of the inflatable balloon, and wherein delivering the energy comprises delivering radiofrequency energy to heat the underlying tissue.

5. The method of claim 4 , wherein the at least one radiofrequency member comprises multiple flexible electrodes that flex outward when the inflatable balloon is inflated.

6. The method of claim 3 , wherein delivering the energy comprises delivering a form of energy selected from the group consisting of radiofrequency, ultrasound, microwave, heat, electrical, light and laser energy.

Assignments (2)
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2020
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 053584/0606 →
Continuity (8)
Continuation 16041101 · Jul 20, 2018
Continuation In Part 15480575 · Apr 6, 2017
Continuation 15380812 · Dec 15, 2016
Continuation 14963719 · Dec 9, 2015
Continuation 13495879 · Jun 13, 2012
Provisional Application 61603864 · Feb 27, 2012
Provisional Application 61496930 · Jun 14, 2011
Related Publication 20200375648A1 · Dec 3, 2020
Cited By (12)
US 12,336,750 US 12,357,378 US 12,357,817 US 12,364,532 US 12,369,963 US 12,369,966 US 12,369,973 US 12,471,978 US 12,527,618 US 12,636,058 US 12,636,073 US 12,678,212